Change

In € millions

 

20031

 

2004

 

20052

 

2006

 

2007

 

20083

 

2009

 

2010

 

2011

 

2012

1

The 2003 figures have not been restated to IFRS accounting standards.

2

The 2003–2005 figures have not been restated for the Organon BioSciences divestment.

3

Continuing operations from ICI are included as from 2008. The 2008 figures have not been restated for the National Starch divestment.

4

Restated to present Decorative Paints North America as a discontinued operation.

Intangible assets

 

590

 

448

 

488

 

682

 

669

 

7,172

 

7,388

 

7,308

 

7,392

 

4,454

Property, plant and equipment

 

3,967

 

3,535

 

3,432

 

3,346

 

2,203

 

3,357

 

3,474

 

3,384

 

3,705

 

3,739

Financial non-current assets

 

1,866

 

1,418

 

1,800

 

1,706

 

1,402

 

1,848

 

1,783

 

1,977

 

2,198

 

2,763

Total non-current assets

 

6,423

 

5,401

 

5,720

 

5,734

 

4,274

 

12,377

 

12,645

 

12,669

 

13,295

 

10,956

Inventories

 

2,133

 

1,978

 

1,987

 

2,042

 

1,177

 

1,781

 

1,441

 

1,678

 

1,924

 

1,545

Receivables

 

2,671

 

2,761

 

2,910

 

2,919

 

2,164

 

2,977

 

2,666

 

2,896

 

3,035

 

2,789

Cash and cash equivalents

 

727

 

1,811

 

1,486

 

1,871

 

11,628

 

1,595

 

2,128

 

2,851

 

1,635

 

1,752

Assets held for sale

 

 

 

322

 

219

 

 

4

 

 

 

 

921

Total current assets

 

5,531

 

6,550

 

6,705

 

7,051

 

14,969

 

6,357

 

6,235

 

7,425

 

6,594

 

7,007

Shareholders’ equity

 

2,502

 

2,605

 

3,415

 

4,144

 

11,032

 

7,463

 

7,775

 

8,984

 

9,212

 

6,892

Minority interests

 

140

 

140

 

161

 

119

 

97

 

450

 

470

 

525

 

531

 

465

Total equity

 

2,642

 

2,745

 

3,576

 

4,263

 

11,129

 

7,913

 

8,245

 

9,509

 

9,743

 

7,357

Provisions

 

3,333

 

2,877

 

2,210

 

2,132

 

1,598

 

2,072

 

1,919

 

1,855

 

1,717

 

1,717

Long-term borrowings

 

2,717

 

2,392

 

2,702

 

2,551

 

1,954

 

2,341

 

3,641

 

2,880

 

3,035

 

3,388

Other non-current liabilities

 

590

 

200

 

183

 

181

 

133

 

715

 

674

 

589

 

567

 

442

Total non-current liabilities

 

6,640

 

5,469

 

5,095

 

4,864

 

3,685

 

5,128

 

6,234

 

5,324

 

5,319

 

5,547

Short-term borrowings

 

441

 

560

 

357

 

410

 

1,635

 

1,338

 

384

 

907

 

494

 

662

Current portion of provisions

 

 

500

 

766

 

571

 

518

 

845

 

797

 

593

 

551

 

455

Other current liabilities

 

2,231

 

2,677

 

2,571

 

2,652

 

2,276

 

3,510

 

3,220

 

3,761

 

3,782

 

3,632

Liabilities held for sale

 

 

 

60

 

25

 

 

 

 

 

 

310

Total current liabilities

 

2,672

 

3,737

 

3,754

 

3,658

 

4,429

 

5,693

 

4,401

 

5,261

 

4,827

 

5,059

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Invested capital

 

8,117

 

7,145

 

8,007

 

8,060

 

5,197

 

13,424

 

11,732

 

12,718

 

12,6134

 

11,030

Capital expenditures

 

581

 

551

 

514

 

371

 

359

 

534

 

513

 

534

 

6584

 

826

Depreciation

 

599

 

540

 

528

 

349

 

330

 

453

 

424

 

435

 

4194

 

463

OWC

 

 

 

 

 

 

 

 

 

 

 

2,359

 

1,691

 

2,016

 

1,8914

 

1,659

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ratios

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue/invested capital

 

1.56

 

1.68

 

1.68

 

1.85

 

1.91

 

1.07

 

1.06

 

1.15

 

1.164

 

1.40

Equity/non-current assets

 

0.41

 

0.51

 

0.62

 

0.74

 

2.60

 

0.64

 

0.65

 

0.75

 

0.73

 

0.67

Inventories and receivables/other current liabilities

 

2.15

 

1.77

 

1.90

 

1.87

 

1.47

 

1.36

 

1.28

 

1.22

 

1.31

 

1.19

Operating working capital as % of revenue

 

 

 

 

 

 

 

 

 

 

 

16.5

 

13.7

 

13.9

 

13.24

 

11.2

Case studies

Part of our contribution
to the world around us

Show case study overview

Interactive key figures

Select and compare key data,
create your own charts

Key figures comparison
Keyword Search
Copyright © 2013 Akzo Nobel N.V.